Cargando…
Small-cell carcinoma of the prostate with negative CD56, NSE, Syn, and CgA indicators: A case report
BACKGROUND: Small-cell carcinoma of the prostate (SCCP) is a clinically rare malignant tumor, accounting for < 1% of all prostate tumors. However, negativity for all SCCP neuroendocrine markers is rare. Herein, we report a case of SCCP with completely negative neuroendocrine markers and explore i...
Autores principales: | Shi, Hong-Jin, Fan, Zhi-Nan, Zhang, Jin-Song, Xiong, Bo-Bo, Wang, Hai-Feng, Wang, Jian-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855255/ https://www.ncbi.nlm.nih.gov/pubmed/35211603 http://dx.doi.org/10.12998/wjcc.v10.i5.1630 |
Ejemplares similares
-
Combined test of serum CgA and NSE improved the power of prognosis prediction of NF-pNETs
por: Lv, Yang, et al.
Publicado: (2017) -
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A
por: Dong, Yunlong, et al.
Publicado: (2020) -
CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016) -
Salivary Chromogranin A (CgA) Response to the Noradrenaline Transporter Blocker Atomoxetine in Dogs
por: Kooriyama, Takanori, et al.
Publicado: (2021) -
Compositional changes in fecal microbiota in a new Parkinson's disease model: C57BL/6-Tg(NSE-haSyn) mice
por: Kim, Ji Eun, et al.
Publicado: (2023)